Do you recommend using IL-1/IL-6 inhibitors in COVID-19 multisystem inflammatory syndrome in adults (MIS-A)?

Topics: Rheumatology • COVID-19 • Macrophage activation syndrome • Autoinflammatory disorders • IL-6 Inhibitors • IL-1 Inhibitors

Answer from: at Academic Institution

There are very few published reports on the COVID-19 multi-inflammatory syndrome in adults (MIS-A), so most of the evidence is extrapolated from the experience of multi-inflammatory syndrome in children (MIS-C). MIS-A seems to occur very infrequently, typically in young adults, despite COVID-19 seve...

Comments

at NIH/NIAID
What is the difference between MIS-A and MAS/HLH?&...

Related Questions